What does the Gemtesa (vibegron) FDA label say it’s for?
Gemtesa (vibegron) is FDA-approved to treat overactive bladder (OAB) in adults with symptoms of urinary urgency, increased urinary frequency, and urinary incontinence or urgency urinary incontinence. [1]
How is Gemtesa (vibegron) taken according to the label?
The FDA label specifies dosing for adults and provides guidance on administration (including whether it should be taken with or without food) and overall use as a once-daily treatment for OAB. [1]
What are the most important warnings and precautions on the Gemtesa label?
The FDA label includes boxed or prominent safety information where applicable and lists precautions tied to vibegron’s clinical effects and observed adverse reactions in studies. These sections cover what clinicians and patients should watch for during treatment. [1]
What side effects does the Gemtesa FDA label report?
The label lists adverse reactions observed in clinical trials and identifies which events occurred more often than with placebo, along with any key clinical guidance related to those reactions. [1]
Are there kidney or liver dose adjustments mentioned on the label?
The FDA label describes dosing considerations in patients with renal impairment and any available information for hepatic impairment, including whether dose changes are recommended. [1]
What drug interactions are highlighted in the FDA label?
The label includes drug-interaction information relevant to how vibegron is handled in the body (and any interaction warnings for commonly used medications). [1]
How to find the exact FDA prescribing information
The prescribing information (“label”) for Gemtesa is available via the FDA label document. If you want, tell me whether you need the patient-friendly guide or the full clinician label, and I can point you to the specific section (indications, dosing, warnings, adverse reactions, interactions, or clinical studies). [1]
Sources
[1] FDA label for Gemtesa (vibegron) — https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761226